Financhill
Back

Revance Therapeutics Vs. Recursion Pharmaceuticals Industry Stock Comparison

Sell
10

RVNC
Revance Therapeutics

Last Price:
3.84
Seasonality Move:
2.15%
Sell
48

RXRX
Recursion Pharmaceuticals

Last Price:
5.74
Seasonality Move:
6.36%
Sell
10
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $3.80. The Score for RVNC is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
48
Recursion Pharmaceuticals (RXRX) is a Sell

Is Recursion Pharmaceuticals a Buy, Sell or Hold?

  • The current Recursion Pharmaceuticals [RXRX] share price is $6.04. The Score for RXRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • RXRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $3.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight buying pressure.

RXRX Stock Price Chart

What is Recursion Pharmaceuticals's stock price today?

  • The Recursion Pharmaceuticals share price today is $6.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing slight selling pressure.

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 33.4 Sell
Chaikin Money Flow: -30034 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

RXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 40.35 Sell
Chaikin Money Flow: 241279 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.98 Sell
20-day SMA: 4.91 Sell
50-day SMA: 5.27 Sell
200-day SMA: 4.62 Sell
8-day EMA: 4.13 Sell
20-day EMA: 4.63 Sell
50-day EMA: 5.02 Sell
200-day EMA: 6.06 Sell

RXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.78 Sell
20-day SMA: 6.73 Sell
50-day SMA: 6.65 Sell
200-day SMA: 8.36 Sell
8-day EMA: 6.5 Sell
20-day EMA: 6.66 Sell
50-day EMA: 6.75 Sell
200-day EMA: 7.72 Sell

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Recursion Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):